Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK and NEW ORLEANS, Feb. 13, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.

PRNewsWire • Feb 14, 2026

INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands

INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.

Zacks Investment Research • Feb 12, 2026

Inspire Medical: Still A Long Way From A Good Night's Sleep

Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance implies just 4–10% revenue growth, higher capex, and a projected net loss amid operational challenges. Valuation remains stretched even after a 66% stock decline; DCF analysis suggests current pricing bakes in optimistic growth and margin assumptions.

Seeking Alpha • Feb 12, 2026

Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript

Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 12, 2026

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42 Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2025. “We are very excited with the strong finish to 2025.

GlobeNewsWire • Feb 11, 2026

Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates

Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago.

Zacks Investment Research • Feb 11, 2026

Inspire (INSP) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Evaluate the expected performance of Inspire (INSP) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research • Feb 10, 2026

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Investment Research • Feb 5, 2026

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 4, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Investment Research • Feb 3, 2026